Clinical Trial Update: A Feasibility Study of Ketorolac Treatment for Cachexia in Patients With Advanced Pancreatic Ductal Adenocarcinoma [EARLY_Phase 1]

View source ↗

Summary

This clinical trial update describes an early-phase feasibility study of ketorolac for cachexia in patients with advanced pancreatic ductal adenocarcinoma, whic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Toradol (ketorolac tromethamine)

Snippet

Sponsor: Andrew Hendifar, MD | Conditions: Pancreas Cancer, Pancreatic Ductal Adenocarcinoma | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING